Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Comparative efficacy and safety of combination therapies for advanced melanoma: a network meta-analysis

Fig. 2

Network plot for OS of nine different treatment regimens for patients. The lines represent direct comparisons within the RCTs. The line thickness indicates the number of RCTs included in each comparison. BRAF_MEK: combination of BRAF and MEK inhibitors; CTLA-4_Adju: combination of CTLA-4 blockade and an adjuvant; CTLA-4_chemo: combination of CTLA-4 blockade and chemotherapy; MEK_chemo: combination of a MEK inhibitor and chemotherapy; Adju: adjuvant; Chemo: chemotherapy

Back to article page
\